comparemela.com

Latest Breaking News On - குறி சர்டி - Page 1 : comparemela.com

INTERVIEW | Debt-for-asset swap was the best move for Ascendis, says CEO Mark Sardi

Ascendis' woes stem from its ambitious debt-funded acquisition spree that saw it snap up a number of businesses in Europe.

Piet Viljoen on Ascendis, Transaction Capital and his own portfolio

Piet Viljoen on Ascendis, Transaction Capital and his own portfolio Piet Viljoen, fund manager of the Counterpoint Value Fund, joined the BizNews Power Hour as co-host. Viljoen, who has both Ascendis and Transaction Capital in his portfolio, weighed in on the recent developments with both companies. K nown to many as one of the last purists out there in respect of value investing, Viljoen applied his keen understanding to a host of topics, including Naspers and Prosus as well as which clues an investor should look out for to see whether or not management is overreaching. – Nadya Swart Piet Viljoen on the view that Ascendis CEO Mark Sardi made it possible for shareholders to get something out when they might have got nothing:

Ascendis: CEO Mark Sardi and activists agree on path forward

Ascendis Health forges a deal with its lenders to settle R7 61bn debt

Ascendis Health forges a deal with its lenders to settle R7.61bn debt By Sandile Mchunu Share DURBAN - ASCENDIS Health yesterday reached an agreement with its lenders for the restructuring and recapitalisation agreement with its creditors Blantyre Capital and L1 Health for the settlement of its outstanding debt of €447 million (R7.61 billion). However, the group said the proposed transaction required 75 percent of shareholder approval, adding that if it did not receive the required shareholder support, the senior lenders would be able to enforce their rights and Ascendis Health would be placed in business rescue. The agreement comes after Blantyre Capital and L1 Health increased their exposure to the company s debt to more than 75 percent of the aggregate exposure of the company s consortium of external lenders in February.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.